NAMI vs TAL

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 19, 2026

NAMI

35.4
AI Score
VS
TAL Wins

TAL

52.1
AI Score

Investment Advisor Scores

NAMI

35score
Recommendation
AVOID NEW MONEY

TAL

52score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric NAMI TAL Winner
Forward P/E 0 9.4697 Tie
PEG Ratio 0 2.7854 Tie
Revenue Growth -31.9% 31.9% TAL
Earnings Growth 0.0% 1360.0% TAL
Tradestie Score 35.4/100 52.1/100 TAL
Profit Margin -23.9% 28.4% TAL
Beta 1.00 1.00 Tie
AI Recommendation AVOID NEW MONEY HOLD TAL

Relative Price Performance (Last 90 Days)

NAMI 1M: -6.6% · 3M: -42.5% TAL 1M: +0.7% · 3M: +15.2%

Current Technical Phase

NAMI

Markdown
Sell / avoid

Price below a falling SMA50 (slope -15.7%), weak momentum, RSI 42

RSI (14): 42.3 · Price: $1.85

TAL

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 44

RSI (14): 44.3 · Price: $11.89

Fundamentals Snapshot

Metric NAMI TAL
Market Cap — —
Forward P/E 0.0 15.1
Trailing P/E 0.9 7.5
Revenue (TTM) — —
Revenue Growth -0.3% 0.3%
Gross Margin 0.1% 0.6%
Operating Margin -0.1% 0.2%
EPS 1.93 1.60
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, TAL is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.